Zheng Zhou

Bldg 5, 720 Cailun Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Spatio-temporal evolution in habitat quality and its driving factors in Han River Basin, China.

Spatio-temporal evolution in habitat quality and its driving factors in Han River Basin, China.

Journal: Scientific reports

Published: April 14, 2025

Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus.

Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus.

Journal: Journal of medicinal chemistry

Published: October 06, 2023

Hydrological regimes and water quality variations in the Yangtze River basin from 1998 to 2018.

Hydrological regimes and water quality variations in the Yangtze River basin from 1998 to 2018.

Journal: Water research

Published: June 27, 2023

Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection.

Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection.

Journal: Journal of medicinal chemistry

Published: March 10, 2023

Discovery of Pyrido[2,3-b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV.

Discovery of Pyrido[2,3-b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV.

Journal: Journal of medicinal chemistry

Published: August 14, 2020

Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling.

Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling.

Journal: Cell reports

Published: February 12, 2020

A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.

A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.

Journal: Journal of medicinal chemistry

Published: November 06, 2019

Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator.

Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator.

Journal: Hepatology (Baltimore, Md.)

Published: June 02, 2018

Discovery of potent and selective CDK8 inhibitors through FBDD approach.

Discovery of potent and selective CDK8 inhibitors through FBDD approach.

Journal: Bioorganic & medicinal chemistry letters

Published: June 15, 2017

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors.

Journal: Journal of medicinal chemistry

Published: March 25, 2017

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms.

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms.

Journal: Scientific reports

Published: October 06, 2016

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.

Journal: Journal of medicinal chemistry

Published: July 27, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026